| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | FLNA FLNB FLNC ANK2 MAP1B MYO5B VEZT OBSCN HIP1R ADNP WASH6P WASH3P ALMS1 CDK5RAP2 GNAS AKAP1 USH2A MTSS2 | 2.06e-05 | 1099 | 107 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.46e-05 | 231 | 107 | 8 | GO:0005085 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.63e-04 | 151 | 107 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | alcohol binding | 2.22e-04 | 102 | 107 | 5 | GO:0043178 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RALGDS MYCBP2 SLC38A9 ARHGEF5 DOCK9 NUCB1 NUCB2 OBSCN TNS3 MTSS2 | 3.96e-04 | 507 | 107 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RALGDS MYCBP2 SLC38A9 ARHGEF5 DOCK9 NUCB1 NUCB2 OBSCN TNS3 MTSS2 | 3.96e-04 | 507 | 107 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | ethanol binding | 4.21e-04 | 6 | 107 | 2 | GO:0035276 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate binding | 4.88e-04 | 121 | 107 | 5 | GO:1902936 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase inhibitor activity | 7.80e-04 | 8 | 107 | 2 | GO:0141039 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 9.39e-04 | 36 | 107 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 9.39e-04 | 36 | 107 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | actin binding | 1.10e-03 | 479 | 107 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | gamma-tubulin binding | 1.10e-03 | 38 | 107 | 3 | GO:0043015 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RALGDS MYCBP2 PI16 SLC38A9 ARHGEF5 DOCK9 NUCB1 NUCB2 OBSCN RICTOR NEK9 WASH6P WASH3P BRPF1 GNAS TNS3 MTSS2 | 1.40e-03 | 1418 | 107 | 17 | GO:0030234 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.52e-03 | 11 | 107 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 1.58e-03 | 43 | 107 | 3 | GO:0001965 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 1.71e-03 | 95 | 107 | 4 | GO:0005546 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | ACACB MAP1B MYO5B MYCBP2 PI16 ADNP KIAA0319 ALMS1 SGPL1 FOXP1 GNAS CXADR | 2.85e-06 | 421 | 111 | 12 | GO:0048638 |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | FLNA ANK2 TMEM165 NUCB2 RYR3 ATP13A3 ATP2A1 ATP2A2 CNGB1 IMMT | 2.44e-05 | 359 | 111 | 10 | GO:0006874 |
| GeneOntologyBiologicalProcess | protein localization to M-band | 2.87e-05 | 2 | 111 | 2 | GO:0036309 | |
| GeneOntologyBiologicalProcess | actin filament-based process | FLNA FLNB FLNC ANK2 MYO5B ARHGEF5 OBSCN HIP1R RICTOR WASH6P WASH3P ALMS1 AMOTL2 ATP2A1 ATP2A2 CXADR | 2.97e-05 | 912 | 111 | 16 | GO:0030029 |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | FLNA ANK2 TMEM165 NUCB2 RYR3 ATP13A3 ATP2A1 ATP2A2 CNGB1 IMMT | 4.82e-05 | 389 | 111 | 10 | GO:0055074 |
| GeneOntologyBiologicalProcess | negative regulation of developmental growth | 6.18e-05 | 126 | 111 | 6 | GO:0048640 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 7.63e-05 | 81 | 111 | 5 | GO:0098900 | |
| GeneOntologyBiologicalProcess | muscle cell development | 8.04e-05 | 259 | 111 | 8 | GO:0055001 | |
| GeneOntologyBiologicalProcess | regulation of muscle adaptation | 8.35e-05 | 133 | 111 | 6 | GO:0043502 | |
| GeneOntologyBiologicalProcess | positive regulation of endoplasmic reticulum calcium ion concentration | 8.58e-05 | 3 | 111 | 2 | GO:0032470 | |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 8.58e-05 | 3 | 111 | 2 | GO:0046186 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 9.13e-05 | 44 | 111 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | negative regulation of cardiac muscle hypertrophy | 9.98e-05 | 45 | 111 | 4 | GO:0010614 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.07e-04 | 87 | 111 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | action potential | 1.09e-04 | 201 | 111 | 7 | GO:0001508 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle hypertrophy | 1.19e-04 | 47 | 111 | 4 | GO:0014741 | |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy | 1.20e-04 | 142 | 111 | 6 | GO:0003300 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | FLNA ANK2 ARHGEF5 HIP1R RICTOR WASH6P WASH3P ALMS1 ATP2A1 ATP2A2 | 1.28e-04 | 438 | 111 | 10 | GO:0032970 |
| GeneOntologyBiologicalProcess | striated muscle hypertrophy | 1.40e-04 | 146 | 111 | 6 | GO:0014897 | |
| GeneOntologyBiologicalProcess | muscle hypertrophy | 1.50e-04 | 148 | 111 | 6 | GO:0014896 | |
| GeneOntologyBiologicalProcess | muscle system process | FLNA ANK2 ACACB PI16 RYR3 P2RX4 SLMAP FOXP1 AKAP1 ATP2A1 ATP2A2 | 1.79e-04 | 547 | 111 | 11 | GO:0003012 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle hypertrophy | 1.79e-04 | 97 | 111 | 5 | GO:0010611 | |
| GeneOntologyBiologicalProcess | regulation of muscle hypertrophy | 2.07e-04 | 100 | 111 | 5 | GO:0014743 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 2.07e-04 | 100 | 111 | 5 | GO:0061337 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | FLNA ANK2 ACACB ERN1 TMEM165 NUCB2 ADNP RYR3 ALMS1 ATP13A3 ATP2A1 ATP2A2 CNGB1 IMMT | 2.28e-04 | 866 | 111 | 14 | GO:0055082 |
| GeneOntologyBiologicalProcess | cellular homeostasis | FLNA ANK2 ACACB ERN1 TMEM165 NUCB2 ADNP RYR3 ALMS1 CHD6 ATP13A3 ATP2A1 ATP2A2 CNGB1 IMMT | 2.45e-04 | 981 | 111 | 15 | GO:0019725 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | FLNA FLNC ARHGEF5 CDS2 OBSCN WASH6P WASH3P ALMS1 CDK5RAP2 TNS3 | 2.47e-04 | 475 | 111 | 10 | GO:0140694 |
| GeneOntologyBiologicalProcess | muscle adaptation | 2.62e-04 | 164 | 111 | 6 | GO:0043500 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 2.71e-04 | 392 | 111 | 9 | GO:0070588 | |
| GeneOntologyBiologicalProcess | regulation of growth | ACACB MAP1B MYO5B MYCBP2 PI16 RICTOR ADNP KIAA0319 ALMS1 SGPL1 FOXP1 GNAS CXADR | 2.79e-04 | 777 | 111 | 13 | GO:0040008 |
| GeneOntologyBiologicalProcess | endosome to plasma membrane protein transport | 2.83e-04 | 24 | 111 | 3 | GO:0099638 | |
| GeneOntologyBiologicalProcess | regulation of AV node cell action potential | 2.84e-04 | 5 | 111 | 2 | GO:0098904 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 2.84e-04 | 5 | 111 | 2 | GO:0006117 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 3.19e-04 | 317 | 111 | 8 | GO:0090257 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | FLNA FLNB FLNC MYO5B ARHGEF5 OBSCN HIP1R RICTOR WASH6P WASH3P ALMS1 AMOTL2 CXADR | 3.82e-04 | 803 | 111 | 13 | GO:0030036 |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol import | 4.24e-04 | 6 | 111 | 2 | GO:1904109 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 5.01e-04 | 29 | 111 | 3 | GO:1903779 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 5.54e-04 | 30 | 111 | 3 | GO:0098901 | |
| GeneOntologyBiologicalProcess | calcium ion import into sarcoplasmic reticulum | 5.92e-04 | 7 | 111 | 2 | GO:1990036 | |
| GeneOntologyBiologicalProcess | regulation of system process | FLNA ANK2 ACACB PI16 HIP1R P2RX4 FOXP1 GNAS AKAP1 ATP2A1 ATP2A2 CXADR | 5.94e-04 | 734 | 111 | 12 | GO:0044057 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | FLNA MAP1B ARHGEF5 HIP1R RICTOR WASH6P WASH3P ALMS1 CDK5RAP2 | 6.05e-04 | 438 | 111 | 9 | GO:1902903 |
| GeneOntologyBiologicalProcess | regulation of Arp2/3 complex-mediated actin nucleation | 6.11e-04 | 31 | 111 | 3 | GO:0034315 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid localization | 6.68e-04 | 129 | 111 | 5 | GO:1905954 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 8.04e-04 | 34 | 111 | 3 | GO:0086019 | |
| GeneOntologyCellularComponent | I band | 2.55e-07 | 166 | 111 | 9 | GO:0031674 | |
| GeneOntologyCellularComponent | Z disc | 1.45e-06 | 151 | 111 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | myofibril | 1.98e-06 | 273 | 111 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.39e-06 | 290 | 111 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | costamere | 5.12e-06 | 22 | 111 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | sarcomere | 7.34e-06 | 249 | 111 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | sarcolemma | 7.98e-06 | 190 | 111 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.45e-04 | 94 | 111 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | A band | 1.68e-04 | 52 | 111 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | recycling endosome | 1.85e-04 | 222 | 111 | 7 | GO:0055037 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 2.24e-04 | 56 | 111 | 4 | GO:0031234 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 4.13e-04 | 6 | 111 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 4.13e-04 | 6 | 111 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 4.13e-04 | 6 | 111 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 4.65e-04 | 185 | 111 | 6 | GO:0009898 | |
| GeneOntologyCellularComponent | intercalated disc | 4.72e-04 | 68 | 111 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | M band | 5.88e-04 | 31 | 111 | 3 | GO:0031430 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 7.66e-04 | 8 | 111 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | cell cortex | 8.24e-04 | 371 | 111 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 9.82e-04 | 9 | 111 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.23e-03 | 223 | 111 | 6 | GO:0098862 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.44e-03 | 230 | 111 | 6 | GO:0098562 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.44e-03 | 230 | 111 | 6 | GO:0019898 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.49e-03 | 11 | 111 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.76e-03 | 45 | 111 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | alpha-beta T cell receptor complex | 1.78e-03 | 12 | 111 | 2 | GO:0042105 | |
| GeneOntologyCellularComponent | anchoring junction | FLNA FLNB FLNC ANK2 VEZT ARHGEF5 OBSCN FNDC1 AHNAK AMOTL2 ATP2A2 CXADR TNS3 | 2.01e-03 | 976 | 111 | 13 | GO:0070161 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 2.52e-03 | 443 | 111 | 8 | GO:0098791 | |
| GeneOntologyCellularComponent | WASH complex | 2.80e-03 | 15 | 111 | 2 | GO:0071203 | |
| GeneOntologyCellularComponent | sarcoplasm | 3.21e-03 | 114 | 111 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 3.21e-03 | 114 | 111 | 4 | GO:0005798 | |
| GeneOntologyCellularComponent | endosome | ANK2 MYO5B SLC38A9 TMEM165 NUCB1 KIAA0319 WASH6P WASH3P GOLIM4 AP1M1 ATP13A3 GNAS AMOTL2 PRLR | 3.52e-03 | 1167 | 111 | 14 | GO:0005768 |
| GeneOntologyCellularComponent | actin cytoskeleton | 3.61e-03 | 576 | 111 | 9 | GO:0015629 | |
| GeneOntologyCellularComponent | BLOC-1 complex | 4.04e-03 | 18 | 111 | 2 | GO:0031083 | |
| GeneOntologyCellularComponent | cell-cell junction | 4.27e-03 | 591 | 111 | 9 | GO:0005911 | |
| HumanPheno | Broad phalanges of the thumb | 3.05e-05 | 8 | 43 | 3 | HP:0009651 | |
| HumanPheno | Accessory carpal bones | 6.96e-05 | 2 | 43 | 2 | HP:0004232 | |
| HumanPheno | Bipartite calcaneus | 6.96e-05 | 2 | 43 | 2 | HP:0008127 | |
| HumanPheno | Hyperostosis frontalis interna | 6.96e-05 | 2 | 43 | 2 | HP:0004438 | |
| Domain | Filamin | 2.29e-09 | 11 | 105 | 5 | PF00630 | |
| Domain | FILAMIN_REPEAT | 2.29e-09 | 11 | 105 | 5 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 2.29e-09 | 11 | 105 | 5 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 2.29e-09 | 11 | 105 | 5 | IPR017868 | |
| Domain | IG_FLMN | 1.93e-07 | 10 | 105 | 4 | SM00557 | |
| Domain | Ig-like_fold | FLNA FLNB FLNC MYCBP2 OBSCN HEPACAM2 KIAA0319 FNDC1 HMCN2 EBI3 NFATC2 POGLUT2 TRBC1 USH2A PRLR CXADR | 2.00e-06 | 706 | 105 | 16 | IPR013783 |
| Domain | Ig_E-set | 2.66e-05 | 104 | 105 | 6 | IPR014756 | |
| Domain | FN3 | 8.39e-05 | 185 | 105 | 7 | SM00060 | |
| Domain | - | FLNA FLNB FLNC MYCBP2 OBSCN HEPACAM2 FNDC1 EBI3 NFATC2 POGLUT2 USH2A PRLR CXADR | 8.78e-05 | 663 | 105 | 13 | 2.60.40.10 |
| Domain | P-type_ATPase_IIA | 9.36e-05 | 3 | 105 | 2 | IPR005782 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.11e-04 | 17 | 105 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.11e-04 | 17 | 105 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 1.32e-04 | 18 | 105 | 3 | PF00690 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.57e-04 | 19 | 105 | 3 | IPR004014 | |
| Domain | FN3_dom | 1.79e-04 | 209 | 105 | 7 | IPR003961 | |
| Domain | ACTININ_2 | 2.82e-04 | 23 | 105 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.82e-04 | 23 | 105 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.82e-04 | 23 | 105 | 3 | IPR001589 | |
| Domain | PHR | 3.10e-04 | 5 | 105 | 2 | IPR012983 | |
| Domain | PHR | 3.10e-04 | 5 | 105 | 2 | PF08005 | |
| Domain | - | 7.61e-04 | 32 | 105 | 3 | 3.40.1110.10 | |
| Domain | - | 7.61e-04 | 32 | 105 | 3 | 2.70.150.10 | |
| Domain | ADH_Zn_CS | 8.57e-04 | 8 | 105 | 2 | IPR002328 | |
| Domain | ADH_ZINC | 8.57e-04 | 8 | 105 | 2 | PS00059 | |
| Domain | ATPase_P-typ_cyto_domN | 9.91e-04 | 35 | 105 | 3 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.08e-03 | 36 | 105 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 1.08e-03 | 36 | 105 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.08e-03 | 36 | 105 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.17e-03 | 37 | 105 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.17e-03 | 37 | 105 | 3 | PF00122 | |
| Domain | Hydrolase_3 | 1.37e-03 | 10 | 105 | 2 | PF08282 | |
| Domain | fn3 | 2.22e-03 | 162 | 105 | 5 | PF00041 | |
| Domain | SANT | 2.79e-03 | 50 | 105 | 3 | SM00717 | |
| Domain | SANT/Myb | 3.12e-03 | 52 | 105 | 3 | IPR001005 | |
| Domain | PKS_ER | 3.57e-03 | 16 | 105 | 2 | IPR020843 | |
| Domain | ATPase_P-typ_TM_dom | 3.57e-03 | 16 | 105 | 2 | IPR023298 | |
| Domain | ADH_N | 3.57e-03 | 16 | 105 | 2 | PF08240 | |
| Domain | - | 3.57e-03 | 16 | 105 | 2 | 1.20.1110.10 | |
| Domain | PKS_ER | 3.57e-03 | 16 | 105 | 2 | SM00829 | |
| Domain | ADH_N | 3.57e-03 | 16 | 105 | 2 | IPR013154 | |
| Domain | - | 4.52e-03 | 18 | 105 | 2 | 3.90.180.10 | |
| Domain | Cation_ATPase_N | 4.52e-03 | 18 | 105 | 2 | SM00831 | |
| Domain | ADH_zinc_N | 5.03e-03 | 19 | 105 | 2 | PF00107 | |
| Domain | ADH_SF_Zn-type | 5.03e-03 | 19 | 105 | 2 | IPR002085 | |
| Domain | ADH_C | 5.03e-03 | 19 | 105 | 2 | IPR013149 | |
| Domain | FN3 | 5.34e-03 | 199 | 105 | 5 | PS50853 | |
| Domain | RCC1 | 5.57e-03 | 20 | 105 | 2 | PF00415 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 2.51e-05 | 11 | 77 | 3 | M48099 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 5.82e-05 | 76 | 77 | 5 | MM15051 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.05e-04 | 86 | 77 | 5 | M916 | |
| Pubmed | FLNA FLNB ZNF536 ACACB MYCBP2 ZCCHC8 ADNP RFX1 NEK9 ALMS1 AHNAK BUB1 FOXP1 CHD6 AKAP1 | 6.68e-12 | 418 | 112 | 15 | 34709266 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA FLNB FLNC MAP1B MYCBP2 POLE SMCHD1 HIP1R RICTOR ADNP NEK9 SF3B3 TFB1M AIFM1 SGPL1 AHNAK ACIN1 AP1M1 ATP2A2 IMMT TNS3 AHNAK2 | 3.35e-10 | 1353 | 112 | 22 | 29467282 |
| Pubmed | FLNB FLNC REPS1 ANK2 MYCBP2 DOCK9 OBSCN GON4L NEK9 ALMS1 SLMAP CDK5RAP2 AKAP1 ATP2A1 | 8.27e-10 | 497 | 112 | 14 | 23414517 | |
| Pubmed | FLNA FLNB FLNC MAP1B MYCBP2 ZCCHC8 POLE SMCHD1 KRI1 ADNP AHNAK ACIN1 ATP2A2 IMMT | 2.61e-08 | 653 | 112 | 14 | 22586326 | |
| Pubmed | FLNA REPS1 MAP1B MYCBP2 SMCHD1 ADNP RFX1 NEK9 TFAP2A ALMS1 AHNAK ACIN1 AMOTL2 | 2.68e-08 | 549 | 112 | 13 | 38280479 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA FLNB FLNC MAP1B MYO5B MYCBP2 SMCHD1 ADNP ZNF512B SF3B3 AIFM1 AHNAK ACIN1 GNAS ATP2A2 IMMT CXADR | 3.21e-08 | 1024 | 112 | 17 | 24711643 |
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 12393796 | ||
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 11153914 | ||
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 11252955 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNA FLNB FLNC MYCBP2 RICTOR SF3B3 AIFM1 AHNAK BRPF1 GNAS ATP2A1 ATP2A2 PGM2 IMMT AHNAK2 | 5.21e-08 | 807 | 112 | 15 | 30575818 |
| Pubmed | 7.29e-08 | 234 | 112 | 9 | 36243803 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAP1B MYCBP2 ZCCHC8 ARHGEF5 RICTOR NEK9 ALMS1 AHNAK AP1M1 FOXO4 GNAS AKAP1 TNS3 AHNAK2 MTSS2 | 1.20e-07 | 861 | 112 | 15 | 36931259 |
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 11739414 | ||
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 1.30e-07 | 4 | 112 | 3 | 22802962 | |
| Pubmed | MAP1B TMEM165 KRI1 GON4L TFB1M AIFM1 SGPL1 AHNAK ASCC2 GNAS ATP2A2 IMMT | 2.16e-07 | 547 | 112 | 12 | 37267103 | |
| Pubmed | ANK2 MYCBP2 VEZT POLE NUCB1 NUCB2 KRI1 RICTOR ZNF512B SF3B3 AIFM1 SLMAP ASCC2 CDK5RAP2 GNAS AKAP1 ATP2A2 IMMT CXADR | 2.76e-07 | 1487 | 112 | 19 | 33957083 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 12006559 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 17360453 | ||
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 3.24e-07 | 5 | 112 | 3 | 11701968 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 19366992 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLNA REPS1 ANK2 ACACB MAP1B ZCCHC8 SMCHD1 ADNP NEK9 ZNF512B ALMS1 AHNAK ACIN1 AKAP1 AHNAK2 | 3.39e-07 | 934 | 112 | 15 | 33916271 |
| Pubmed | 3.90e-07 | 46 | 112 | 5 | 33403043 | ||
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 6.46e-07 | 6 | 112 | 3 | 18159949 | |
| Pubmed | FLNA FLNB FLNC ANK2 ACACB MAP1B MYO5B SMCHD1 NUCB1 NUCB2 ANKRD30B SF3B3 AHNAK ACIN1 CHD6 ATP2A1 ATP2A2 IMMT | 8.28e-07 | 1442 | 112 | 18 | 35575683 | |
| Pubmed | Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development. | 8.83e-07 | 54 | 112 | 5 | 31792442 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | FLNA FLNB FLNC TMEM165 CDS2 NUCB1 NUCB2 RFX1 SF3B3 FADS3 AIFM1 SGPL1 AHNAK GOLIM4 GNAS POGLUT2 ATP2A2 IMMT | 9.04e-07 | 1451 | 112 | 18 | 30550785 |
| Pubmed | 1.13e-06 | 7 | 112 | 3 | 16076904 | ||
| Pubmed | RALGDS SMCHD1 HIP1R KBTBD2 ADNP ZNF512B SF3B3 SLMAP CDK5RAP2 AMOTL2 ZNF646 | 1.20e-06 | 529 | 112 | 11 | 14621295 | |
| Pubmed | 1.80e-06 | 8 | 112 | 3 | 11784029 | ||
| Pubmed | MEKK4 signaling regulates filamin expression and neuronal migration. | 1.80e-06 | 8 | 112 | 3 | 17145501 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.80e-06 | 8 | 112 | 3 | 19033399 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNA FLNB FLNC MAP1B HIP1R ADNP SF3B3 AIFM1 AHNAK GOLIM4 ACIN1 AP1M1 GNAS ATP2A2 IMMT TNS3 AHNAK2 | 1.82e-06 | 1367 | 112 | 17 | 32687490 |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 1.90e-06 | 256 | 112 | 8 | 24189400 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | FLNA MAP1B SMCHD1 KRI1 ADNP RFX1 TFAP2A ZNF512B SF3B3 AHNAK ACIN1 ATP2A1 ATP2A2 IMMT | 2.47e-06 | 954 | 112 | 14 | 36373674 |
| Pubmed | 2.69e-06 | 9 | 112 | 3 | 11807098 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FLNA FLNC MAP1B MYCBP2 TFAP2A SF3B3 AHNAK BRPF1 ASCC2 ATP2A2 TNS3 AHNAK2 | 4.00e-06 | 724 | 112 | 12 | 36232890 |
| Pubmed | 4.35e-06 | 202 | 112 | 7 | 24639526 | ||
| Pubmed | 4.87e-06 | 76 | 112 | 5 | 27542412 | ||
| Pubmed | 5.26e-06 | 11 | 112 | 3 | 36579465 | ||
| Pubmed | 6.54e-06 | 215 | 112 | 7 | 30462309 | ||
| Pubmed | 6.54e-06 | 215 | 112 | 7 | 35973513 | ||
| Pubmed | 7.00e-06 | 12 | 112 | 3 | 30013108 | ||
| Pubmed | ZNF536 ACACB TMEM165 POLE CDS2 RFX1 TFAP2A MANBAL CDK5RAP2 CHD6 AHNAK2 | 7.15e-06 | 638 | 112 | 11 | 31182584 | |
| Pubmed | MYO5B MYCBP2 VEZT KRI1 RICTOR TFAP2A ZNF512B AIFM1 AHNAK GOLIM4 CDK5RAP2 ATP2A2 CXADR TNS3 | 7.31e-06 | 1049 | 112 | 14 | 27880917 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12556521 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 29489384 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 11303599 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 19644701 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 17635842 | ||
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles. | 1.03e-05 | 2 | 112 | 2 | 14638697 | |
| Pubmed | A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha. | 1.03e-05 | 2 | 112 | 2 | 9694715 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 27859969 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15007166 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 7689010 | ||
| Pubmed | Filamin depletion blocks endoplasmic spreading and destabilizes force-bearing adhesions. | 1.03e-05 | 2 | 112 | 2 | 21325628 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 10679933 | ||
| Pubmed | Calnuc binds to Alzheimer's beta-amyloid precursor protein and affects its biogenesis. | 1.03e-05 | 2 | 112 | 2 | 17348862 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15718407 | ||
| Pubmed | Modulation of nucleobindin-1 and nucleobindin-2 by caspases. | 1.03e-05 | 2 | 112 | 2 | 18154733 | |
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 1.03e-05 | 2 | 112 | 2 | 24469451 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 11402072 | ||
| Pubmed | A novel FLNC frameshift and an OBSCN variant in a family with distal muscular dystrophy. | 1.03e-05 | 2 | 112 | 2 | 29073160 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 21653697 | ||
| Pubmed | The limits of promiscuity: isoform-specific dimerization of filamins. | 1.03e-05 | 2 | 112 | 2 | 12525170 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 33664869 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 11336782 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 33649519 | ||
| Pubmed | Sarco(endo)plasmic reticulum Ca2+ ATPase isoforms and their role in muscle physiology and pathology. | 1.03e-05 | 2 | 112 | 2 | 10603953 | |
| Pubmed | Characterizing SERCA Function in Murine Skeletal Muscles after 35-37 Days of Spaceflight. | 1.03e-05 | 2 | 112 | 2 | 34769190 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 18953100 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 20833135 | ||
| Pubmed | SERCA overexpression reduces hydroxyl radical injury in murine myocardium. | 1.03e-05 | 2 | 112 | 2 | 16798816 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12975374 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | FLNA FLNB BTBD6 SMCHD1 KRI1 RICTOR ALMS1 USH2A ATP2A2 NKAPL IMMT | 1.13e-05 | 670 | 112 | 11 | 22990118 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNA FLNB MYO5B SMCHD1 KRI1 ADNP SF3B3 SGPL1 AHNAK SLMAP ASCC2 ACIN1 AP1M1 GNAS IMMT | 1.27e-05 | 1257 | 112 | 15 | 36526897 |
| Pubmed | ZNF536 ACACB SMCHD1 KRI1 GON4L ADNP RFX1 ZNF512B ALMS1 PAX8 AIFM1 ELF1 FOXP1 CHD6 ATP2A2 IMMT | 1.40e-05 | 1429 | 112 | 16 | 35140242 | |
| Pubmed | 1.41e-05 | 242 | 112 | 7 | 34011540 | ||
| Pubmed | ZNF536 VEZT ZCCHC8 TMEM165 RICTOR ZNF512B SF3B3 HMCN2 ALMS1 SGPL1 BRPF1 CRNN FOXP1 ZNF646 | 1.46e-05 | 1116 | 112 | 14 | 31753913 | |
| Pubmed | FLNA FLNB MYCBP2 SMCHD1 NUCB1 NUCB2 FADS3 AIFM1 AHNAK GOLIM4 GNAS POGLUT2 AKAP1 ATP2A2 PGM2 | 1.83e-05 | 1297 | 112 | 15 | 33545068 | |
| Pubmed | FLNB REPS1 ANK2 MAP1B TMEM165 RICTOR SF3B3 AIFM1 AHNAK ATP2A2 IMMT | 1.88e-05 | 708 | 112 | 11 | 39231216 | |
| Pubmed | FLNB ZCCHC8 KRI1 TFAP2A ZNF512B SF3B3 SGPL1 BRPF1 CRNN ACIN1 FOXP1 ATP2A2 | 1.92e-05 | 847 | 112 | 12 | 35850772 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.99e-05 | 583 | 112 | 10 | 29844126 | |
| Pubmed | 2.23e-05 | 591 | 112 | 10 | 15231748 | ||
| Pubmed | 2.26e-05 | 104 | 112 | 5 | 9205841 | ||
| Pubmed | 2.28e-05 | 360 | 112 | 8 | 33111431 | ||
| Pubmed | FLNA MYCBP2 DOCK9 CDS2 NUCB1 P2RX4 AHNAK BUB1 GOLIM4 AP1M1 ATP13A3 GNAS AKAP1 IMMT | 2.42e-05 | 1168 | 112 | 14 | 19946888 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 2.56e-05 | 18 | 112 | 3 | 12119179 | |
| Pubmed | 2.65e-05 | 267 | 112 | 7 | 33417871 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 2.71e-05 | 268 | 112 | 7 | 33024031 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 2.76e-05 | 370 | 112 | 8 | 22922362 | |
| Pubmed | 3.00e-05 | 488 | 112 | 9 | 31324722 | ||
| Pubmed | 3.03e-05 | 19 | 112 | 3 | 35941131 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 16132793 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 11960985 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 2474823 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 2737681 | ||
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 3.08e-05 | 3 | 112 | 2 | 23772048 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 8163197 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 3.08e-05 | 3 | 112 | 2 | 24787690 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 28175289 | ||
| Interaction | PHF21A interactions | FLNA FLNB ZNF536 ACACB MYCBP2 ZCCHC8 NEK9 ALMS1 AHNAK BUB1 CHD6 AKAP1 | 4.69e-07 | 343 | 112 | 12 | int:PHF21A |
| Interaction | CCDC8 interactions | FLNA FLNB MAP1B MYO5B MYCBP2 SMCHD1 ADNP ZNF512B SF3B3 AIFM1 AHNAK GNAS ATP2A2 IMMT CXADR | 3.51e-06 | 656 | 112 | 15 | int:CCDC8 |
| Interaction | HSPB8 interactions | 5.35e-06 | 172 | 112 | 8 | int:HSPB8 | |
| Interaction | HDAC1 interactions | FLNA FLNB ZNF536 ACACB MYCBP2 ZCCHC8 GON4L ADNP RFX1 NEK9 ZNF512B ALMS1 NFATC2 AIFM1 AHNAK BUB1 ASCC2 CDK5RAP2 AKAP1 | 1.07e-05 | 1108 | 112 | 19 | int:HDAC1 |
| Interaction | CDCA5 interactions | 1.33e-05 | 140 | 112 | 7 | int:CDCA5 | |
| Interaction | CIT interactions | FLNA FLNB FLNC SMCHD1 KRI1 ADNP SF3B3 ALMS1 TFB1M PAX8 AIFM1 AHNAK ACIN1 CDK5RAP2 ELF1 GNAS ATP2A1 ATP2A2 NKAPL PGM2 IMMT AHNAK2 | 1.35e-05 | 1450 | 112 | 22 | int:CIT |
| Interaction | KDM1A interactions | FLNA FLNB ACACB MYCBP2 ZCCHC8 ADNP RFX1 NEK9 ALMS1 NFATC2 AHNAK BUB1 ASCC2 FOXP1 CHD6 AKAP1 IMMT | 1.70e-05 | 941 | 112 | 17 | int:KDM1A |
| Interaction | RCOR1 interactions | FLNA ZNF536 ACACB MYCBP2 ZCCHC8 NEK9 ALMS1 NFATC2 AHNAK BUB1 CHD6 AKAP1 | 1.98e-05 | 494 | 112 | 12 | int:RCOR1 |
| Interaction | PER2 interactions | 2.36e-05 | 153 | 112 | 7 | int:PER2 | |
| Interaction | DUSP16 interactions | 5.40e-05 | 237 | 112 | 8 | int:DUSP16 | |
| Interaction | SIRT7 interactions | FLNA FLNB FLNC MAP1B MYCBP2 ZCCHC8 POLE SMCHD1 KRI1 ADNP AHNAK ACIN1 ATP2A2 IMMT | 6.54e-05 | 744 | 112 | 14 | int:SIRT7 |
| Interaction | ATOH1 interactions | 8.36e-05 | 80 | 112 | 5 | int:ATOH1 | |
| Interaction | FBXL6 interactions | MAP1B TMEM165 KRI1 GON4L TFB1M AIFM1 SGPL1 AHNAK ASCC2 GNAS ATP2A2 IMMT | 9.75e-05 | 583 | 112 | 12 | int:FBXL6 |
| Interaction | ARMCX3 interactions | 9.96e-05 | 133 | 112 | 6 | int:ARMCX3 | |
| Interaction | PRELID2 interactions | 1.07e-04 | 17 | 112 | 3 | int:PRELID2 | |
| Interaction | LGR4 interactions | 1.09e-04 | 262 | 112 | 8 | int:LGR4 | |
| Interaction | NUDC interactions | 1.11e-04 | 337 | 112 | 9 | int:NUDC | |
| Interaction | ECT2 interactions | FLNA FLNB FLNC MYO5B MYCBP2 KRI1 SF3B3 AIFM1 AHNAK ACIN1 GNAS ATP2A1 ATP2A2 IMMT AHNAK2 | 1.17e-04 | 887 | 112 | 15 | int:ECT2 |
| Interaction | MARCHF5 interactions | 1.50e-04 | 205 | 112 | 7 | int:MARCHF5 | |
| Interaction | FNDC5 interactions | FLNA FLNB FLNC TMEM165 CDS2 NUCB1 NUCB2 RFX1 ADH1C SF3B3 FADS3 AIFM1 SGPL1 AHNAK CRNN GOLIM4 GNAS POGLUT2 ATP2A2 IMMT | 1.60e-04 | 1470 | 112 | 20 | int:FNDC5 |
| Interaction | PTPN12 interactions | 1.60e-04 | 145 | 112 | 6 | int:PTPN12 | |
| Interaction | YWHAG interactions | FLNA MYCBP2 ARHGEF5 DOCK9 RICTOR SF3B3 ALMS1 NFATC2 ACIN1 AP1M1 PPIP5K1 FOXO4 GNAS AMOTL2 PRLR TNS3 AHNAK2 MTSS2 | 1.74e-04 | 1248 | 112 | 18 | int:YWHAG |
| Interaction | MECOM interactions | 1.75e-04 | 358 | 112 | 9 | int:MECOM | |
| Interaction | WASH4P interactions | 1.82e-04 | 4 | 112 | 2 | int:WASH4P | |
| Interaction | FBLIM1 interactions | 1.85e-04 | 51 | 112 | 4 | int:FBLIM1 | |
| Interaction | PLEKHG7 interactions | 1.92e-04 | 150 | 112 | 6 | int:PLEKHG7 | |
| Interaction | AIFM1 interactions | FLNA FLNB FLNC MAP1B RICTOR NFATC2 AIFM1 SGPL1 ATP13A3 AKAP1 ATP2A2 IMMT | 1.98e-04 | 629 | 112 | 12 | int:AIFM1 |
| Interaction | EXOG interactions | 1.99e-04 | 52 | 112 | 4 | int:EXOG | |
| Interaction | AGR2 interactions | FLNA FLNB FLNC MYCBP2 RICTOR SF3B3 AIFM1 AHNAK BRPF1 GNAS ATP2A1 ATP2A2 PGM2 IMMT AHNAK2 | 2.05e-04 | 934 | 112 | 15 | int:AGR2 |
| Interaction | JSRP1 interactions | 2.07e-04 | 21 | 112 | 3 | int:JSRP1 | |
| Interaction | MYOT interactions | 2.07e-04 | 21 | 112 | 3 | int:MYOT | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 3.27e-05 | 16 | 72 | 3 | 14 | |
| GeneFamily | Alcohol dehydrogenases | 4.31e-04 | 8 | 72 | 2 | 397 | |
| GeneFamily | ATPases Ca2+ transporting | 5.53e-04 | 9 | 72 | 2 | 1209 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.23e-03 | 53 | 72 | 3 | 532 | |
| GeneFamily | EF-hand domain containing | 1.80e-03 | 219 | 72 | 5 | 863 | |
| GeneFamily | Fibronectin type III domain containing | 3.81e-03 | 160 | 72 | 4 | 555 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_500 | FLNC MAP1B PI16 RYR3 GSTT1 FNDC1 AHNAK SLMAP ATP13A3 ATP2A2 AHNAK2 | 5.09e-06 | 388 | 109 | 11 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500 |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.98e-07 | 188 | 112 | 7 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.54e-07 | 191 | 112 | 7 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.58e-07 | 196 | 112 | 7 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-07 | 200 | 112 | 7 | 93e13937ec74418a697c37d56f57509fb2154780 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 7.54e-07 | 200 | 112 | 7 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.59e-06 | 163 | 112 | 6 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.85e-06 | 165 | 112 | 6 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.27e-06 | 168 | 112 | 6 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.73e-06 | 171 | 112 | 6 | e6dfbd2652b67577c8834c05348f62150637f348 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.73e-06 | 171 | 112 | 6 | ddaeb96ce9c9c3bf232b4a42266fa2ee7e8f3f41 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.96e-06 | 178 | 112 | 6 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.56e-06 | 181 | 112 | 6 | ab0f300d14b62cef57f1b0bdae143b8dfe8e6975 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-06 | 181 | 112 | 6 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.98e-06 | 183 | 112 | 6 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-06 | 186 | 112 | 6 | 5d0cd07b6b51e8ce9e1da949f757dc4575ec5752 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.90e-06 | 187 | 112 | 6 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.14e-06 | 188 | 112 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 8.65e-06 | 190 | 112 | 6 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.18e-06 | 192 | 112 | 6 | 1b0138fd0bfdee266325751f8b2d163d91a71bf5 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-06 | 192 | 112 | 6 | 6417468829517a0f6e04e7e44eec1622001d4c5c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.46e-06 | 193 | 112 | 6 | 465061688bc09c6d8adc2f662a385dab8918ebbf | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.46e-06 | 193 | 112 | 6 | 3d85c28f6ebdcb15e875ad01d52d6c138fbf8525 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Tregs|blood / Manually curated celltypes from each tissue | 9.46e-06 | 193 | 112 | 6 | 2ffe44edf2b02d11a7c10513692eb697a10f911e | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class | 9.74e-06 | 194 | 112 | 6 | c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9 | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|(2)_5-FU / Stress and Cell class | 1.03e-05 | 196 | 112 | 6 | cc0a172de71d9a1a882c9e78652dae70e007d012 | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 1.06e-05 | 197 | 112 | 6 | 434ae0231972acba12d06279908cf407e70511ac | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 1.06e-05 | 197 | 112 | 6 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-05 | 197 | 112 | 6 | 470e23dee4ca35e1fd021b7cdd58fcbc90639837 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.09e-05 | 198 | 112 | 6 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 198 | 112 | 6 | 2d0c14f8cabab99bc6d7c27685437c78841c7245 | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.09e-05 | 198 | 112 | 6 | 9f9dcf23ffb333105263132d87b90095642294cf | |
| ToppCell | (03)_KRT6B+|World / shred by cell type by condition | 1.13e-05 | 199 | 112 | 6 | 9feaf8649b3f68f30b8cb6b045a2caa2dd343c7f | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.16e-05 | 200 | 112 | 6 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.16e-05 | 200 | 112 | 6 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.16e-05 | 200 | 112 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | (03)_Secretory-(1)_24hpi|(03)_Secretory / shred by cell type and Timepoint | 2.34e-05 | 135 | 112 | 5 | 6e473296dfe1ff7a63d701e56920c0a1b043ddc6 | |
| ToppCell | Healthy-B_cell|World / disease group, cell group and cell class | 3.41e-05 | 146 | 112 | 5 | 588359d3df6ad7090b7fa6c7f8d29cc1717e7f4f | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.76e-05 | 149 | 112 | 5 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 4.40e-05 | 154 | 112 | 5 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.53e-05 | 155 | 112 | 5 | 5687416773809b8c478567bc54310af102b3029a | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.82e-05 | 157 | 112 | 5 | f1c6c313836352271033d23efd31b0f0a8a09e02 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.27e-05 | 160 | 112 | 5 | 8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.27e-05 | 160 | 112 | 5 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.27e-05 | 160 | 112 | 5 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.27e-05 | 160 | 112 | 5 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.93e-05 | 164 | 112 | 5 | 8f3255d7f67890389a768453492243ea982eb38a | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.28e-05 | 166 | 112 | 5 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 167 | 112 | 5 | 1248f809afbcccb42ce9e29cfe6fa1f6f6b65005 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 167 | 112 | 5 | a66552667aa6e8992c159df27a57c2e8ae14a9ce | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.23e-05 | 171 | 112 | 5 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.23e-05 | 171 | 112 | 5 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.84e-05 | 174 | 112 | 5 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.84e-05 | 174 | 112 | 5 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.84e-05 | 174 | 112 | 5 | 0f3ec0d0d4344e10c9b48adc9174123f6402dc51 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.84e-05 | 174 | 112 | 5 | 1aadbf2642b6d1320ceabd92e6ff59e11f16c315 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.06e-05 | 175 | 112 | 5 | 8269721389a3ce98681460e6393f2cff816eaa25 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.28e-05 | 176 | 112 | 5 | 6b1cf1e98b4509e87f9eea827fa7090ce1e504f1 | |
| ToppCell | Mild-Lymphoid-T-innate_T|Mild / Condition, Lineage, Cell class and cell subclass | 8.96e-05 | 179 | 112 | 5 | abc0fbe101a464a2c85755a974a3d5c2b968fe46 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.96e-05 | 179 | 112 | 5 | bc95c3e7edc5fc6fc913b09f087d221df64c6f48 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.20e-05 | 180 | 112 | 5 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 180 | 112 | 5 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 180 | 112 | 5 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.20e-05 | 180 | 112 | 5 | a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 180 | 112 | 5 | a0faed4cf23f6d5e6e8f6b0284cea8a5bd0680a0 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 180 | 112 | 5 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.44e-05 | 181 | 112 | 5 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.44e-05 | 181 | 112 | 5 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.44e-05 | 181 | 112 | 5 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | Severe-Lymphoid-T-innate_T|Severe / Condition, Lineage, Cell class and cell subclass | 9.44e-05 | 181 | 112 | 5 | 50ab8562552339d97e4f19aa6ae49fd797da492e | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-05 | 181 | 112 | 5 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.44e-05 | 181 | 112 | 5 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.69e-05 | 182 | 112 | 5 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.69e-05 | 182 | 112 | 5 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.69e-05 | 182 | 112 | 5 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.69e-05 | 182 | 112 | 5 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 184 | 112 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 184 | 112 | 5 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.05e-04 | 185 | 112 | 5 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 185 | 112 | 5 | e583f6601f9ed79b0b23d2f9426a4ba8b969230b | |
| ToppCell | P03|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-04 | 185 | 112 | 5 | a07dbe1f76e40734a28826423a5cc64b8e56af5e | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 185 | 112 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-04 | 185 | 112 | 5 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-04 | 186 | 112 | 5 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-04 | 186 | 112 | 5 | 9c7924875f70420720149287c500b4dfa8d24673 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-NK_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-04 | 186 | 112 | 5 | b099cb0902e9afb11218d70407d3cab212343c6d | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.10e-04 | 187 | 112 | 5 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 187 | 112 | 5 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 188 | 112 | 5 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-04 | 188 | 112 | 5 | 9db3d3010cb8a1f3ee1cdccaf3cbaac3cf983fc5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-04 | 188 | 112 | 5 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-04 | 188 | 112 | 5 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.13e-04 | 188 | 112 | 5 | 72be6fe654f3a5f654d3b9680145bce7ae9b721d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.13e-04 | 188 | 112 | 5 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 188 | 112 | 5 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 188 | 112 | 5 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-04 | 189 | 112 | 5 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 4.13e-08 | 3 | 103 | 3 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 4.13e-08 | 3 | 103 | 3 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | RALGDS FLNC ANK2 MAP1B POLE RBP3 OBSCN PAX8 BUB1 ACIN1 GNAS ZNF572 | 6.35e-06 | 702 | 103 | 12 | C0009402 |
| Disease | Brody myopathy (implicated_via_orthology) | 3.61e-05 | 3 | 103 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | Profound Mental Retardation | 1.30e-04 | 139 | 103 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.30e-04 | 139 | 103 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.30e-04 | 139 | 103 | 5 | C0917816 | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 1.79e-04 | 6 | 103 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | Periventricular Nodular Heterotopia | 2.51e-04 | 7 | 103 | 2 | C1868720 | |
| Disease | IGF-1 measurement | 3.19e-04 | 488 | 103 | 8 | EFO_0004627 | |
| Disease | level of Phosphatidylcholine (16:0_20:5) in blood serum | 4.28e-04 | 9 | 103 | 2 | OBA_2045077 | |
| Disease | level of Phosphatidylcholine (18:0_20:5) in blood serum | 4.28e-04 | 9 | 103 | 2 | OBA_2045095 | |
| Disease | alpha wave measurement, electroencephalogram measurement | 5.33e-04 | 10 | 103 | 2 | EFO_0004357, EFO_0006870 | |
| Disease | myopathy (implicated_via_orthology) | 6.37e-04 | 48 | 103 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Amelogenesis Imperfecta | 7.78e-04 | 12 | 103 | 2 | C0002452 | |
| Disease | Disorder of eye | 9.04e-04 | 212 | 103 | 5 | C0015397 | |
| Disease | alcohol dependence measurement | 9.50e-04 | 55 | 103 | 3 | EFO_0007835 | |
| Disease | Intellectual Disability | 9.93e-04 | 447 | 103 | 7 | C3714756 | |
| Disease | Malignant neoplasm of breast | FLNA FLNB ANK2 OBSCN HEPACAM2 FSCB TFAP2A GOLIM4 AP1M1 GABRA4 ZNF646 | 1.33e-03 | 1074 | 103 | 11 | C0006142 |
| Disease | Eye Abnormalities | 1.59e-03 | 17 | 103 | 2 | C0015393 | |
| Disease | esophageal adenocarcinoma, digestive system disease, Barrett's esophagus | 1.78e-03 | 18 | 103 | 2 | EFO_0000280, EFO_0000405, EFO_0000478 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.83e-03 | 148 | 103 | 4 | C0279702 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.99e-03 | 19 | 103 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | metabolite measurement, diet measurement | 1.99e-03 | 71 | 103 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | Retinitis pigmentosa | 2.24e-03 | 74 | 103 | 3 | cv:C0035334 | |
| Disease | lung cancer (is_implicated_in) | 2.24e-03 | 74 | 103 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 2.43e-03 | 21 | 103 | 2 | DOID:4914 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 2.43e-03 | 21 | 103 | 2 | OBA_2045076 | |
| Disease | renal system measurement, blood urea nitrogen measurement | 2.66e-03 | 22 | 103 | 2 | EFO_0004741, EFO_0004742 | |
| Disease | Epilepsy, Cryptogenic | 3.00e-03 | 82 | 103 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 3.00e-03 | 82 | 103 | 3 | C0751111 | |
| Disease | Aura | 3.00e-03 | 82 | 103 | 3 | C0236018 | |
| Disease | coronary artery disease | ANKRD31 REPS1 MAP1B TMEM165 DOCK9 NEK9 KIAA0319 ENAM FNDC1 SF3B3 TNS3 | 3.03e-03 | 1194 | 103 | 11 | EFO_0001645 |
| Disease | congenital heart disease (is_implicated_in) | 3.17e-03 | 24 | 103 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | Brugada Syndrome (disorder) | 3.17e-03 | 24 | 103 | 2 | C1142166 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DEEPVTFPKSTHVPI | 301 | Q6UXB8 | |
| LASAPEVPHKPAVEA | 81 | Q8N6Y0 | |
| VEVALPPPAEHEVKK | 956 | Q9UKV3 | |
| VSHEKPPDPAAVAAA | 16 | Q8N944 | |
| PEEPVVLALDPKGHE | 746 | Q9H2P0 | |
| TEEPVVTAPPAAHAK | 706 | Q9Y2J4 | |
| HLAPEEVNKAPVFVP | 1891 | A6H8Y1 | |
| HTELAKDDAAPAPPV | 276 | Q92667 | |
| GDPAIFPAVIVEHVP | 26 | P32519 | |
| ERHVPTAADVPKVPL | 386 | Q4G0S4 | |
| IEESPEKPSHFEPAT | 906 | Q9BXX2 | |
| LPSKPKEEVPHAEEF | 561 | O43683 | |
| PFSIEEVEVAPPKAH | 21 | P07327 | |
| EEVPQDKAPSHVPFL | 121 | O95831 | |
| PSAIDPEAIPVKLVH | 801 | Q9H7F0 | |
| VKSEIHIPDVEPAAF | 176 | Q96KE9 | |
| PFSIEEVEVAPPKAH | 21 | P00326 | |
| PAVEKHPGPSDTVVF | 1056 | Q12774 | |
| EAPKPDHFVQDPAVL | 671 | Q9H1I8 | |
| SELVEPAFVPPKEVD | 2681 | Q8TCU4 | |
| EIHIPVPNDADSPKF | 311 | Q9BXS5 | |
| QRVAHEPVAPPEDKE | 6 | O95674 | |
| SLPHAIEEVPHVEDP | 151 | P05549 | |
| PKVDIDAPDVDVHGP | 2746 | Q09666 | |
| PKVDIDAPDVDVHGP | 4296 | Q09666 | |
| SVIKHTEPVPDPRAV | 186 | O14983 | |
| AVSIPEVPLQPDKHD | 1641 | Q96SN8 | |
| PVVADPHSPFAIKQE | 296 | Q06710 | |
| PVEDDTHVPQPAFLK | 166 | Q99571 | |
| LELDDPSKVHPAEPF | 961 | O00763 | |
| KIPEPVQSVPEEESH | 2091 | Q01484 | |
| PEAESPEVLPHIEKE | 136 | Q8N7Z5 | |
| HPVPAIKTEPTDEYD | 676 | Q13469 | |
| EVIEKPPAVPVSFEF | 1351 | P46821 | |
| EAPLEHKPQVEASSP | 856 | Q8TD19 | |
| DVPAEEASVDKHSPP | 706 | Q5H9T9 | |
| IPDSAKVVAFKPEHP | 276 | Q8NDA2 | |
| ELVPHFPARVKVEPA | 1211 | O75369 | |
| EPPEVEPDLGEKVHT | 46 | P98177 | |
| DDLVVLTAEPHKLPP | 226 | Q765P7 | |
| KFNDEHIPDSPFVVP | 2386 | Q14315 | |
| IHITPVDDQLPKEAP | 631 | Q5H8C1 | |
| VLHVEVFPVNDEPPV | 876 | Q5H8C1 | |
| HPVHVKEEPLDPEEA | 631 | Q9H334 | |
| PPADLHKVGTVVTPD | 301 | Q8IY47 | |
| AFKAFDLVPPEAVPE | 266 | Q96G03 | |
| PAVQPEESLKTDHPE | 161 | Q16891 | |
| AQEEEAPVSPHKKPA | 631 | Q8N9T8 | |
| EVPAAPVQREKHPEA | 361 | P48169 | |
| LPPPKHTFEVRAETD | 1546 | Q07864 | |
| NIHPVESAKIEPPDT | 36 | P80303 | |
| KFHPDTDDVPVPAPA | 421 | Q02818 | |
| HEEAEAVLATPPKQP | 1686 | Q6R327 | |
| FADVIVKPHDPATVD | 41 | Q9UBG3 | |
| APTHKEAEFQAPPEP | 306 | O00461 | |
| PEEKPASDVHEQLVP | 5356 | Q5VST9 | |
| APPEEQHLVEAAKLP | 206 | O75344 | |
| SVIKHTDPVPDPRAV | 186 | P16615 | |
| AEHIKPVVVIPEEAP | 296 | O75146 | |
| EVEEFVPCIPKHTQP | 621 | Q9BZ29 | |
| ETHAKDDPLVTPVPA | 41 | Q9UK08 | |
| VLQVPTHVEEPAFLP | 61 | O75460 | |
| KTVQEVHPGEPPFDL | 301 | Q8TD26 | |
| FNEEHIPDSPFVVPV | 2311 | P21333 | |
| DEKPLPATVVNDHVP | 881 | Q4ZHG4 | |
| KEVHHDIREDVPPPK | 271 | P78310 | |
| FITEHIIKPDPPEGV | 121 | Q14213 | |
| PIPSTPEDKAHVNVD | 1216 | Q3T8J9 | |
| PEDDRGPVVPKHSTF | 141 | O95467 | |
| SEEKPHLLVFPPDLV | 376 | Q12967 | |
| IVPIPKSHEAEAEPS | 41 | Q9NQG1 | |
| EKLPDHVPLFSDTVP | 106 | Q96LR7 | |
| TVDDPVTKPVVQIHP | 141 | A8MVW5 | |
| AVYPEEIPSPAKEHF | 546 | Q9NRM1 | |
| PNIFHKDPDVTVAPV | 226 | Q9Y5Q0 | |
| PEEASAFKHVERAPP | 396 | Q9H4Q3 | |
| TPADKALIAPDHVVP | 76 | Q8NBW4 | |
| HEVILKAKDFPPADP | 211 | P30711 | |
| DVVVVDKPSSIPVHP | 231 | Q8IZ73 | |
| TDEDIPEGVPAPKAH | 2236 | O75445 | |
| KHPEVLPAEKASDPA | 651 | Q96D71 | |
| ESAFTVRPLPDEPKH | 1136 | A6NHR9 | |
| PSEAPPLAVHDEAEK | 646 | P22670 | |
| AFVPKPEVDVGVVHF | 216 | Q8WVM0 | |
| HFVASLTPAPVEPEE | 3596 | O75592 | |
| KHFSEAEEPQVPPAV | 146 | B7ZBB8 | |
| LASTEKPPVDIPAHE | 171 | Q5MNZ6 | |
| EPPPVSTVVHFKVSA | 1341 | Q68CZ2 | |
| PHGVIDPVPEVAKLA | 291 | O95470 | |
| VFLEPIDSIEHIPPA | 366 | P55201 | |
| VEVSQPEADLPLPKH | 5111 | Q8IVF2 | |
| EKVIPQPVHSITEDP | 111 | Q14028 | |
| PDTKPAEAEPVEEEH | 611 | Q14028 | |
| PKFPQLDSDEHTPVE | 141 | Q5M9Q1 | |
| VEKPFESPDVGDFPH | 491 | Q7Z3I7 | |
| ELFEPFDHPEESIPK | 11 | Q6NZY4 | |
| VFHSPGELVVEEAPP | 701 | P10745 | |
| DLNKVFPPEVAVFEP | 1 | P01850 | |
| LPTFVNVPKDHPHIE | 1241 | Q15413 | |
| VIHAPLPSPVDKVAA | 141 | Q14BN4 | |
| IPELPTFHTEVAEPL | 291 | A8MWX3 | |
| DPEVIEKPENPETTH | 376 | P16471 | |
| SHLKVELPPDPVEAE | 531 | O15015 | |
| IPELPTFHTEVAEPL | 276 | C4AMC7 | |
| IFTPAAPVHTNKEDP | 71 | Q9HC07 | |
| HKTPVEEVPAAIAPF | 941 | Q15393 | |
| HFPAVDPEKIAVEIP | 166 | Q6UW63 | |
| PEEKPPASLEEKAHV | 56 | O15090 | |
| APITVSKEAPAPVAH | 476 | Q96KM6 | |
| FPPKVAVFEPSEAEI | 6 | A0A5B9 | |
| QPTLHIADKDPIPEE | 526 | Q9HBM0 | |
| PELPTFHTEVAEPLK | 261 | Q9NQA3 | |
| FPKPFVEKPVSAEDH | 191 | Q6PFW1 | |
| HPVASAQKEPEAAVP | 396 | A6NN73 | |
| EVELKAFVAPAPPVE | 351 | Q5VV43 | |
| PLVADLFHDDKDPVP | 586 | Q9ULV0 |